Abstract
Transmissible spongiform encephalopathies (TSEs) form a group of fatal neurodegenerative disorders represented principally by Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI) in humans, and by scrapie and bovine spongiform encephalopathy (BSE) in animals [1]. Also called prion diseases, TSEs have the unique property of being infectious, sporadic or genetic in origin [2]. They are characterised by a silent asymptomatic period, which may be very long (up to 40 years in humans), in the absence of any specific immune or inflammatory response. During the clinical phase of the disease, specific lesions (spongiosis, astrocytosis) which constitute the veritable signature of these diseases are observed in the central nervous system. The outcome is always fatal for the affected animal or person, whose central nervous system inevitably contains, at the clinical stage of the disease, the transmissible agent which is able to infect another individual of the same species. The nature of this unconventional transmissible agent has not yet been fully elucidated. However, TSEs are almost always accompanied by the accumulation of an abnormal form of a protein in the central nervous system naturally produced by the host, the prion protein, PrP. This abnormal form (called PrPSc, for scrapie PrP) sometimes accumulates in brain as amyloid plaques or deposit of which it is the major component. Following the work of Stanley Prusiner [3], a considerable number of experimental findings were accumulated indicating that PrPSc could well be the infectious agent itself [4]. PrPSc derives from the normal PrP form (PrPC for cellular PrP) through post-translational modifications which induce a conformational change and confer on PrPSc a partial resistance to degradation by proteases, as well as a marked insolubility in the presence of detergents leading to the formation of large aggregates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519–550
Parchi P, Gambetti P (1995) Human prion diseases. Curr Opin Neurol 8: 286–293
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144
Prusiner SB, Scott MR, Dearmond SJ, Cohen FE (1998) Prion protein biology. Cell 93:337–348
Bueler H, Aguzzi A, Sailer A et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1347
Ghani AC, Donnelly CA, Ferguson NM, 12 Anderson RM (2000) Assessment of the prevalence of vCJD through testing ton-sils and appendices for abnormal prion 13 protein. Proc R Soc Lond B Biol Sci 267: 23–29
d’Aignaux JN, Cousens SN, Smith PG (2001) Predictability of the UK variant 14 Creutzfeldt-Jakob disease epidemic. Science 294: 1729–1731
Valleron AJ, Boelle PY, Will R, Cesbron JY (2001) Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294: 1726–1728
Wadsworth JD, Joiner S, Hill AF et al. (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358: 171–180
Ironside JW (2000) Pathology of variant Creutzfeldt-Jakob disease. Arch Virol Suppl 16: 143–151
Houston F, Foster JD, Chong A et al. (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356: 999–1000
Hunter N, Foster J, Chong A et al. (2002) Transmission of prion diseases by blood transfusion. J Gen Virol 83: 2897–2905
Llewelyn CA, Hewitt PE, Knight RS et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417–421
Peden AH, Head MW, Ritchie DL et al. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527–528
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Basel AG
About this chapter
Cite this chapter
Lehmann, S., Grassi, J. (2004). Transmissible Spongiform Encephalopathies or Prion Diseases - General Introduction. In: Lehmann, S., Grassi, J. (eds) Techniques in Prion Research. Methods and Tools in Biosciences and Medicine. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7949-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7949-1_1
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-7643-2224-3
Online ISBN: 978-3-0348-7949-1
eBook Packages: Springer Book Archive